Dr Colin Dalton - Chairman and non-executive director
• Experienced pharmaceutical executive and company director
• 40+ years industrial experience
• Board oversight
• Contract negotiation
Other appointments: director Imcyse SA and investment committee member CD3.
Vectura Group PLC, GSK Biologicals SA, Quadrant Technologies, PA Consulting, BP
Previous directorships and board positions:
Observer on the Board of Profibrix B.V., a novel haemostatic product company; Company Director of Innovata PLC; Innovata Biomed Limited; Quadrant Technologies Limited and Quadrant Healthcare Limited; and Director of IP and Corporate Affairs for Vectura Group plc.